Anthem Blue Cross Connecticut CG-SURG-90 Mohs Micrographic Surgery Form
This procedure is not covered
This document addresses Mohs micrographic surgery (MMS), an outpatient procedure used in selective situations to treat malignant neoplasms of the skin. MMS consists of a precise tissue-sparing surgical technique to remove and process skin tissue in successive stages.
Clinical Indications
Medically Necessary:
Mohs micrographic surgery is considered medically necessary for the treatment of basal cell carcinoma, squamous cell carcinoma, melanoma in situ (Stage 0; including lentigo maligna), when the following criteria are met:
- The lesion or tumor meets any of the following:
- Any of the following combinations of anatomic location and size:
- At least 20 mm on trunk and extremities (excluding pretibial region, hands, feet, and ankles); or
- At least 10 mm on scalp, neck and pretibial region; or
- Any size, on the face (central face, cheeks, forehead, eyelids, eyebrows, periorbital, nose, lips, chin, mandible, preauricular and postauricular skin/sulci, temple, ear), genitalia, hands or feet; OR
- Any of the following clinical presentations regardless of anatomic region:
- Deeply infiltrating lesion or difficulty estimating depth of the lesion; or
- Perineural invasion; or
- Poorly-defined borders; or
- Positive margins on recent excision; or
- Rapidly growing lesions in any anatomic area; or
- Recurrent lesion; OR
- Lesions or tumors with aggressive histologic features or at high-risk for recurrence; OR
- Tumors associated with a high-risk of metastasis arising in any of the following areas:
- Chronic fistulas, sinuses or ulcers (including sinuses of osteomyelitis); or
- Chronically inflamed or previously traumatized skin (such as epidermal atrophy or scars/burn scars, post-traumatic wounds, pressure sores/ulcers); or
- Site of prior radiation therapy; OR
- Individual has either of the following:
- Genetic syndrome (such as basal cell nevus syndrome or xeroderma pigmentosum); or
- Immunocompromised condition (such as hematologic malignancy, human immunodeficiency virus [HIV], organ transplantation, or pharmacologic immunosuppression).
- Any of the following combinations of anatomic location and size:
Mohs micrographic surgery is considered medically necessary for the treatment of the following less common cutaneous tumors or lesions when the following criteria are met:
- The lesion to be treated is known to be any of the following:
- Adenocystic carcinoma
- Adnexal carcinoma
- Apocrine/eccrine carcinoma
- Atypical fibroxanthoma
- Bowenoid papulosis
- Dermatofibrosarcoma protuberans
- Extramammary Paget disease
- Leiomyosarcoma
- Malignant fibrous histiocytoma/undifferentiated pleomorphic sarcoma
- Merkel cell carcinoma
- Microcystic adnexal carcinoma
- Mucinous carcinoma
- Sebaceous carcinoma
Not Medically Necessary:
Mohs micrographic surgery is considered not medically necessary when the criteria above have not been met.